-transparent.png){kind=logo}
Two hundred and ninety-two (75%) patients with common "epithelial" tumors of 391 patients with various kinds of malignant ovarian tumors treated at our hospital and other 14 hospitals between 1971 and 1981 were evaluated particularly to determine 1) the prognostic value of the disease stage and 2) results of therapy. Of the 292 patients, 49.8% were classified in Stage I, 12.8% in Stage II, 27.2% in Stage III and 10.1% in Stage IV. The 5-year survival rates for the various stages were: Stage I, 70.2%; Stage II, 50. 0%; Stage III, 3.4%; and Stage IV, 0%. Postoperative chemotherapy was given to 56.9% of the patients. The prognosis of patients with Stage Ia or Ic who received adjuvant chemotherapy improved, as compared to those who were treated with surgery alone. However, the role of chemotherapy in advanced stages (Stage III and IV) remains unclear.
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
November 1975,
Nihon Kyobu Shikkan Gakkai zasshi,
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
August 1965,
Nihon Sanka Fujinka Gakkai zasshi,
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
August 1971,
Deutsche medizinische Wochenschrift (1946),
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
May 1962,
Naika. Internal medicine,
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
October 1976,
Igaku kenkyu. Acta medica,
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
October 1960,
Annals of the New York Academy of Sciences,
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
May 1960,
Minerva ginecologica,
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
January 1957,
Acta obstetricia et gynecologica Scandinavica. Supplement,
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
November 1989,
Nihon Geka Gakkai zasshi,
H Iwasawa, and
S Sekiya, and
T Kaihou, and
H Takamizawa
December 1962,
Minerva medica,
